Skip to main content
Premium Trial:

Request an Annual Quote

New Products: LabCorp's GeneSeq: Cardio

Premium

Laboratory Corporation of America has launched GeneSeq: Cardio, a next-gen sequencing-based test for genetic causes of familial cardiac disease.

According to the company, the test could help identify individuals who may require regular cardiac screening, lifestyle changes, or clinical intervention to prevent the progression of cardiac disease.

The company did not provide details about the genes included in the assay or which sequencing platform it is using for the test.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.